DFSV vs IBB
Dimensional US Small Cap Value ETF vs iShares Biotechnology ETF
- • DFSV has the lower expense ratio at 0.30% vs 0.44% for IBB.
- • DFSV pays a higher dividend yield (1.43%).
Side-by-side metrics
| Metric | DFSV | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.30% | 0.44% |
Dividend yield Trailing 12-month yield. | 1.43% | 0.23% |
AUM Assets under management — bigger funds are typically more liquid. | $7.51B | $7.95B |
YTD return | 15.46% | 3.10% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.10 | 0.74 |
P/E ratio | 14.28 | 23.72 |
Last price | $37.46 | $170.10 |
Inception | — | — |
Issuer | Dimensional | iShares |
DFSV top holdings
| DINO | HF Sinclair Corp | 0.81% |
| OVV | Ovintiv Inc | 0.80% |
| APA | APA Corp | 0.77% |
| BWA | BorgWarner Inc | 0.76% |
| IVZ | Invesco Ltd | 0.75% |
| WCC | WESCO International Inc | 0.72% |
| KNX | Knight-Swift Transportation Holdings Inc Class A | 0.71% |
| WBS | Webster Financial Corp | 0.67% |
| AMKR | Amkor Technology Inc | 0.65% |
| DAR | Darling Ingredients Inc | 0.65% |
IBB top holdings
| AMGN | Amgen Inc | 7.37% |
| GILD | Gilead Sciences Inc | 7.32% |
| VRTX | Vertex Pharmaceuticals Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 6.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.71% |
| ARGX | argenx SE ADR | 3.33% |
| INSM | Insmed Inc | 2.70% |
| BIIB | Biogen Inc | 2.67% |
| NTRA | Natera Inc | 2.40% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.27% |
About DFSV
DFSV (Dimensional US Small Cap Value ETF) is Systematic small-cap value strategy from Dimensional. Managed by Dimensional, the fund carries $7.5B in assets under management, an expense ratio of 0.30%, a dividend yield of 1.43%. Its largest holding is HF Sinclair Corp (DINO), which represents 0.8% of the portfolio. Real Estate is the fund's largest sector exposure at 0.9%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.